POLE c.919A>G (p.Ile307Val), affecting a conserved residue and not reported in public databases, was identified in an individual with four melanomas diagnosed at age 81 and in two of his sisters, diagnosed with melanoma at 55 and breast cancer at 83. This evidence concerns the gene POLE and breast carcinoma.